Australian-owned CJC-1295 NO DAC + IPA 10mg/10mg Lyophilized Powder in PakistanInformation, Results, Side Effects, Reviews
Australian-owned CJC-1295 NO DAC + IPA 10mg/10mg Lyophilized Powder in Pakistan | Order Now Online
Australian-Owned CJC-1295 No DAC + Ipamorelin 10 mg / 10 mg Lyophilized Powder
Australian-Owned CJC-1295 No DAC + Ipamorelin 10 mg / 10 mg Lyophilized Powder is a research-grade dual-peptide formulation supplied as a freeze-dried (lyophilized) powder for laboratory and scientific research. This formulation combines 10 mg of CJC-1295 (No DAC), a modified growth hormone-releasing hormone (GHRH) analogue, with 10 mg of Ipamorelin, a selective ghrelin receptor (GHS-R1a) agonist. Researchers use this peptide combination to investigate growth hormone signaling, endocrine physiology, receptor interactions, and metabolic pathways. Each batch is typically produced under controlled laboratory conditions, tested for purity, and accompanied by a Certificate of Analysis (CoA). This product is intended strictly for laboratory and in vitro research and is not approved for human or veterinary use.
Key benefits (research findings)
Research on CJC-1295 (No DAC) and Ipamorelin suggests this combination may support investigations into:
Growth hormone (GH) secretion through complementary receptor activation.
Growth hormone-releasing hormone (GHRH) and ghrelin receptor signaling pathways.
Insulin-like growth factor-1 (IGF-1) pathway research.
Endocrine regulation and metabolic physiology.
Body composition, protein synthesis, and fat metabolism in experimental models.
Tissue repair, cellular regeneration, and recovery research.
Sleep architecture and circadian growth hormone secretion studies.
Synergistic effects of dual-pathway growth hormone secretagogues in laboratory settings.
Uses (research applications)
CJC-1295 No DAC + Ipamorelin 10 mg / 10 mg Lyophilized Powder is commonly used in laboratory studies involving:
Growth hormone axis and endocrine research.
Peptide receptor pharmacology.
Metabolic and obesity-related investigations.
Exercise physiology and recovery research.
Cellular signaling and molecular biology.
Protein synthesis and connective tissue research.
Drug discovery and preclinical peptide evaluation.
Hormonal regulation and peptide interaction studies.
Product features
Contains 10 mg of CJC-1295 (No DAC) and 10 mg of Ipamorelin per sterile vial.
Lyophilized (freeze-dried) powder for enhanced stability during storage.
Typically ?99% purity, verified using analytical methods such as HPLC and/or LC-MS.
Batch-tested with a Certificate of Analysis (CoA).
Supplied in a sterile, tamper-evident research vial.
Recommended storage: store the lyophilized powder at ?20°C, protected from light and moisture. After reconstitution, refrigerate at 2–8°C according to supplier recommendations.
Submit Your Review ForAustralian-owned CJC-1295 NO DAC + IPA 10mg/10mg Lyophilized Powder in Pakistan
Your email address will not be published. Required fields are marked *










